VectorBuilder Partners With MaxCyte® to Advance Clinical-Grade Cell Engineering

Key Takeaway: VectorBuilder has announced a partnership with MaxCyte to enhance clinical-grade cell engineering. This collaboration aims to leverage both companies' strengths in cell engineering technologies. Further details on the specific objectives or expected outcomes of this partnership were not provided in the announcement.